washington post medicare

News

Medicare, GLP-1 and weight loss

Medicare, Medicaid plan to experiment with covering weight loss drugs

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially benefiting millions of Americans struggling with obesity.

ConsumerAffairs · 1d

Report: Trump Administration planning test of covering GLP-1 drugs through Medicare, Medicaid

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The Washington Post reports.

Gizmodo · 1d

Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity medications.

UnitedHealth says it is under a federal investigation and cooperating

UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading ...

1don MSN

Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

3don MSN

Washington Post editorial slams Obama judge for blocking 'fair and square' GOP defunding of Planned Parenthood

The Washington Post editorial board argued a federal judge's ruling against congressional Medicaid restrictions on abortion ...

The Washington Post22y

Medicare Bills Pass In Congress - The Washington Post

Medicare Bills Pass In Congress Prescription Drug Benefit Is Key To Biggest Changes in 38 Years June 26, 2003 More than 22 years ago Summary By Amy Goldstein ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results